Last reviewed · How we verify
GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver
The primary objective is to determine the galactose single point (GSP) cutoff values to discriminate subjects with different hepatic function. The secondary objective is to analyze the correlations between GSP and other hepatic function assessment methods among this trial subjects.
Details
| Lead sponsor | National Defense Medical Center, Taiwan |
|---|---|
| Phase | PHASE1, PHASE2 |
| Status | COMPLETED |
| Enrolment | 210 |
| Start date | Thu Jul 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Oct 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Galactose Single Point (GSP), Residual Liver Function
Interventions
- Drug: G.S.P. Solution 400 mg/ml I.V. 1.25 ml/kg BW G.S.P. solution after fasting for 6 hours.